Monopar Therapeutics Ratios (2016-2020) | MNPR

Ratios Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020
Efficiency
Assets Average 9.54M8.80M8.17M7.60M6.84M5.97M5.35M9.23M13.10M12.82M15.48M
Equity Average 9.24M8.49M7.85M7.25M6.35M5.45M4.88M8.63M12.51M12.27M14.82M
Invested Capital 2.83M9.62M8.86M8.12M7.58M6.92M5.77M5.13M4.62M12.63M12.40M12.20M17.56M
Leverage & Solvency
Debt to Equity 0.010.01
Debt Ratio 0.010.01
Equity Ratio 0.980.970.970.960.960.950.910.920.910.950.970.950.96
Valuation
Enterprise Value -2.87M-3.55M-4.28M-10.59M-9.78M-8.97M-8.22M-7.62M-6.89M-5.88M-5.13M-4.49M159.77M63.51M66.78M39.48M
Market Capitalization 172.99M76.10M79.33M57.47M
Return Ratios
Return on Capital Employed -1.85%-2.03%-0.38%-0.44%-0.59%-0.71%-0.83%-0.51%
Return on Assets -1.80%-1.96%-0.36%-0.42%-0.54%-0.66%-0.75%-0.47%
Return on Equity -1.85%-2.03%-0.38%-0.44%-0.58%-0.72%-0.83%-0.50%